TMCI
Treace Medical Concepts Inc

332
Mkt Cap
$173.31M
Volume
685,303.00
52W High
$10.79
52W Low
$2.70
PE Ratio
-3.42
TMCI Fundamentals
Price
$2.61
Prev Close
$2.72
Open
$2.76
50D MA
$6.00
Beta
1.15
Avg. Volume
244,067.22
EPS (Annual)
-$0.8975
P/B
1.94
Rev/Employee
$438,903.56
Loading...
Loading...
News
all
press releases
Truist Financial Reaffirms "Hold" Rating for Treace Medical Concepts (NASDAQ:TMCI)
Truist Financial reaffirmed a "hold" rating and set a $4.00 price objective (down previously from $7.00) on shares of Treace Medical Concepts in a research note on Monday...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus rating of "Reduce" by the seven analysts that are currently covering the stock, MarketBeat.com...
MarketBeat·12d ago
News Placeholder
UBS Group Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $5.85
UBS Group dropped their price target on shares of Treace Medical Concepts from $6.50 to $5.85 and set a "neutral" rating on the stock in a research report on Friday...
MarketBeat·12d ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Receives "Underweight" Rating from JPMorgan Chase & Co.
JPMorgan Chase & Co. reissued an "underweight" rating and set a $5.00 target price (down previously from $8.00) on shares of Treace Medical Concepts in a report on Friday...
MarketBeat·12d ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Receives Neutral Rating from BTIG Research
BTIG Research reaffirmed a "neutral" rating on shares of Treace Medical Concepts in a report on Friday...
MarketBeat·12d ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut Treace Medical Concepts from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·13d ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Beats Estimates By $0.02 EPS
Treace Medical Concepts (NASDAQ:TMCI - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.26) EPS for the quarter, beating analysts' consensus estimates...
MarketBeat·13d ago
News Placeholder
Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +7.14% and +1.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +3.45% and +0.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of +55.56% and +6.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago

Latest TMCI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.